NCT05426980View on ClinicalTrials.gov

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

CompletedOBSERVATIONAL
Enrollment

654

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
Trial Locations (4)

1000

University medical center Ljubljana, Ljubljana

2000

University medical center Maribor, Maribor

3000

General and teaching hospital Celje, Celje

Unknown

General hospital Izola, Izola

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

General and Teaching Hospital Celje

OTHER

collaborator

University Medical Centre Ljubljana

OTHER

collaborator

University Medical Centre Maribor

OTHER

collaborator

Izola General Hospital

OTHER

lead

University of Ljubljana

OTHER